LFST - Company ID 0001845257
The table below shows LifeStance Health Group, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $33.11M | -$3.09M | -$21.84M | -$7.89M | $3.31M | $9.91M |
| Capital expenditure | $10.77M | $7.17M | $5.10M | $7.73M | $27.91M | $11.08M |
| Investing cash flow | -$13.91M | -$7.17M | -$5.10M | -$27.55M | -$50.85M | -$11.84M |
| Dividends paid | - | - | - |
LifeStance Health Group, Inc. reported operating cash flow of $146.15M for fiscal year 2025. That is up 36.3% from $107.26M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from $17.05M (FY 2019) to $146.15M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | $49.11M | $0.00 | - | - | - | - |
| Financing cash flow | -$73.04M | -$9.97M | -$2.43M | -$4.89M | $13.51M | $22.59M |